Gemcitabine-Cisplatin Plus Envafolimab in Resectable Biliary Tract Malignancies
Clinical trial NCT07599995 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07599995
- Sponsor
- Sir Run Run Shaw Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-30
- Primary completion
- 2028-03-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.